These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
271 related articles for article (PubMed ID: 23064365)
1. Tpl2 regulates intestinal myofibroblast HGF release to suppress colitis-associated tumorigenesis. Koliaraki V; Roulis M; Kollias G J Clin Invest; 2012 Nov; 122(11):4231-42. PubMed ID: 23064365 [TBL] [Abstract][Full Text] [Related]
2. Intestinal myofibroblast-specific Tpl2-Cox-2-PGE2 pathway links innate sensing to epithelial homeostasis. Roulis M; Nikolaou C; Kotsaki E; Kaffe E; Karagianni N; Koliaraki V; Salpea K; Ragoussis J; Aidinis V; Martini E; Becker C; Herschman HR; Vetrano S; Danese S; Kollias G Proc Natl Acad Sci U S A; 2014 Oct; 111(43):E4658-67. PubMed ID: 25316791 [TBL] [Abstract][Full Text] [Related]
3. ABIN2 Function Is Required To Suppress DSS-Induced Colitis by a Tpl2-Independent Mechanism. Nanda SK; Nagamori T; Windheim M; Amu S; Aviello G; Patterson-Kane J; Arthur JSC; Ley SC; Fallon P; Cohen P J Immunol; 2018 Dec; 201(11):3373-3382. PubMed ID: 30355787 [TBL] [Abstract][Full Text] [Related]
4. Tenascin-C Produced by Intestinal Myofibroblasts Promotes Colitis-associated Cancer Development Through Angiogenesis. Kawamura T; Yamamoto M; Suzuki K; Suzuki Y; Kamishima M; Sakata M; Kurachi K; Setoh M; Konno H; Takeuchi H Inflamm Bowel Dis; 2019 Mar; 25(4):732-741. PubMed ID: 30517646 [TBL] [Abstract][Full Text] [Related]
5. MET Signaling Mediates Intestinal Crypt-Villus Development, Regeneration, and Adenoma Formation and Is Promoted by Stem Cell CD44 Isoforms. Joosten SPJ; Zeilstra J; van Andel H; Mijnals RC; Zaunbrecher J; Duivenvoorden AAM; van de Wetering M; Clevers H; Spaargaren M; Pals ST Gastroenterology; 2017 Oct; 153(4):1040-1053.e4. PubMed ID: 28716720 [TBL] [Abstract][Full Text] [Related]
6. BMI1 and MEL18 Promote Colitis-Associated Cancer in Mice via REG3B and STAT3. Liu X; Wei W; Li X; Shen P; Ju D; Wang Z; Zhang R; Yang F; Chen C; Cao K; Zhu G; Chen H; Chen L; Sui J; Zhang E; Wu K; Wang F; Zhao L; Xi R Gastroenterology; 2017 Dec; 153(6):1607-1620. PubMed ID: 28780076 [TBL] [Abstract][Full Text] [Related]
8. EGFR in Tumor-Associated Myeloid Cells Promotes Development of Colorectal Cancer in Mice and Associates With Outcomes of Patients. Srivatsa S; Paul MC; Cardone C; Holcmann M; Amberg N; Pathria P; Diamanti MA; Linder M; Timelthaler G; Dienes HP; Kenner L; Wrba F; Prager GW; Rose-John S; Eferl R; Liguori G; Botti G; Martinelli E; Greten FR; Ciardiello F; Sibilia M Gastroenterology; 2017 Jul; 153(1):178-190.e10. PubMed ID: 28400195 [TBL] [Abstract][Full Text] [Related]
9. The B-cell tumor promoter Bcl-3 suppresses inflammation-associated colon tumorigenesis in epithelial cells. Tang W; Wang H; Ha HL; Tassi I; Bhardwaj R; Claudio E; Siebenlist U Oncogene; 2016 Dec; 35(48):6203-6211. PubMed ID: 27132515 [TBL] [Abstract][Full Text] [Related]
10. IKKβ acts as a tumor suppressor in cancer-associated fibroblasts during intestinal tumorigenesis. Pallangyo CK; Ziegler PK; Greten FR J Exp Med; 2015 Dec; 212(13):2253-66. PubMed ID: 26621452 [TBL] [Abstract][Full Text] [Related]
11. NPC1L1 knockout protects against colitis-associated tumorigenesis in mice. He J; Shin H; Wei X; Kadegowda AK; Chen R; Xie SK BMC Cancer; 2015 Mar; 15():189. PubMed ID: 25881076 [TBL] [Abstract][Full Text] [Related]
12. Interleukin-17 induces AP-1 activity and cellular transformation via upregulation of tumor progression locus 2 activity. Kim G; Khanal P; Lim SC; Yun HJ; Ahn SG; Ki SH; Choi HS Carcinogenesis; 2013 Feb; 34(2):341-50. PubMed ID: 23125217 [TBL] [Abstract][Full Text] [Related]
13. Tpl2 ablation promotes intestinal inflammation and tumorigenesis in Apcmin mice by inhibiting IL-10 secretion and regulatory T-cell generation. Serebrennikova OB; Tsatsanis C; Mao C; Gounaris E; Ren W; Siracusa LD; Eliopoulos AG; Khazaie K; Tsichlis PN Proc Natl Acad Sci U S A; 2012 May; 109(18):E1082-91. PubMed ID: 22451924 [TBL] [Abstract][Full Text] [Related]
14. Loss of tumor progression locus 2 (tpl2) enhances tumorigenesis and inflammation in two-stage skin carcinogenesis. Decicco-Skinner KL; Trovato EL; Simmons JK; Lepage PK; Wiest JS Oncogene; 2011 Jan; 30(4):389-97. PubMed ID: 20935675 [TBL] [Abstract][Full Text] [Related]
15. MyD88-mediated signaling prevents development of adenocarcinomas of the colon: role of interleukin 18. Salcedo R; Worschech A; Cardone M; Jones Y; Gyulai Z; Dai RM; Wang E; Ma W; Haines D; O'hUigin C; Marincola FM; Trinchieri G J Exp Med; 2010 Aug; 207(8):1625-36. PubMed ID: 20624890 [TBL] [Abstract][Full Text] [Related]
16. MicroRNA 301A Promotes Intestinal Inflammation and Colitis-Associated Cancer Development by Inhibiting BTG1. He C; Yu T; Shi Y; Ma C; Yang W; Fang L; Sun M; Wu W; Xiao F; Guo F; Chen M; Yang H; Qian J; Cong Y; Liu Z Gastroenterology; 2017 May; 152(6):1434-1448.e15. PubMed ID: 28193514 [TBL] [Abstract][Full Text] [Related]
17. Epimorphin deletion inhibits polyposis in the Apcmin/+ mouse model of colon carcinogenesis via decreased myofibroblast HGF secretion. Swietlicki EA; Bala S; Lu J; Shaker A; Kularatna G; Levin MS; Rubin DC Am J Physiol Gastrointest Liver Physiol; 2013 Oct; 305(8):G564-72. PubMed ID: 23886856 [TBL] [Abstract][Full Text] [Related]
18. Mbd2 enables tumourigenesis within the intestine while preventing tumour-promoting inflammation. May S; Owen H; Phesse TJ; Greenow KR; Jones GR; Blackwood A; Cook PC; Towers C; Gallimore AM; Williams GT; Stürzl M; Britzen-Laurent N; Sansom OJ; MacDonald AS; Bird AP; Clarke AR; Parry L J Pathol; 2018 Jul; 245(3):270-282. PubMed ID: 29603746 [TBL] [Abstract][Full Text] [Related]
19. Role of milk fat globule-epidermal growth factor 8 in colonic inflammation and carcinogenesis. Kusunoki R; Ishihara S; Tada Y; Oka A; Sonoyama H; Fukuba N; Oshima N; Moriyama I; Yuki T; Kawashima K; Ansary MM; Tajima Y; Maruyama R; Nabika T; Kinoshita Y J Gastroenterol; 2015 Aug; 50(8):862-75. PubMed ID: 25596854 [TBL] [Abstract][Full Text] [Related]
20. Colonic Epithelial-Derived Selenoprotein P Is the Source for Antioxidant-Mediated Protection in Colitis-Associated Cancer. Short SP; Pilat JM; Barrett CW; Reddy VK; Haberman Y; Hendren JR; Marsh BJ; Keating CE; Motley AK; Hill KE; Zemper AE; Washington MK; Shi C; Chen X; Wilson KT; Hyams JS; Denson LA; Burk RF; Rosen MJ; Williams CS Gastroenterology; 2021 Apr; 160(5):1694-1708.e3. PubMed ID: 33388316 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]